158 results on '"Park, Su-Hyung"'
Search Results
2. Use of a platform with lens-free shadow imaging technology to monitor natural killer cell activity
3. Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer
4. IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the antitumor efficacy of T cell engager immunotherapy
5. A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity
6. Better understanding CD8+ T cells in cancer and viral infections
7. Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma
8. A novel splicing variant of DJ-1 in Parkinson's disease induces mitochondrial dysfunction
9. A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions
10. Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner
11. BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality
12. Oligonucleotide‐Linked Lipid Nanoparticles as a Versatile mRNA Nanovaccine Platform.
13. Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults
14. IL-17A–producing sinonasal MAIT cells in patients with chronic rhinosinusitis with nasal polyps
15. Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets
16. Polyubiquitinated PCNA triggers SLX4-mediated break-induced replication in alternative lengthening of telomeres (ALT) cancer cells.
17. Anti-4-1BB×PD-L1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD-1 Blockade
18. Supplementary Figures S1-11 from CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy
19. Supplementary Tables S1-7 from CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy
20. T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant
21. GX-I7(rhIL-7-hyFc, efineptakin alfa), a long-acting IL-7, safely and effectively increased peripheral CD8+ and CD4+ T cells and TILs in patients with solid tumors
22. Omicron BA.2 breakthrough infection elicits CD8 + T cell responses recognizing the spike of later Omicron subvariants
23. PD-1 blockade improves treatment responses to PARP inhibitors by targeting PD-1+ regulatory T cells in patients with epithelial ovarian cancer
24. PD-1 expression level and BRCA1/2 mutations status determine anti-PD-1-induced reinvigoration of tumor-infiltrating CD8 T cells in advanced-stage epithelial ovarian cancer
25. IL-15 in T-Cell Responses and Immunopathogenesis
26. PR003/#357 Peripheral PD-1+regulatory T cells for predicting treatment response to parp inhibitor maintenance in patients with epithelial ovarian cancer
27. Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie bandavirus in aged ferrets
28. Short-range end resection requires ATAD5-mediated PCNA unloading for faithful homologous recombination
29. Inhalation Delivery of Interferon-λ-Loaded Pulmonary Surfactant Nanoparticles Induces Rapid Antiviral Immune Responses in the Lung.
30. Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie Bandavirus in aged ferrets
31. Polyubiquitinated PCNA promotes alternative lengthening of telomeres by inducing break-induced replication
32. Lamin A/C facilitates DNA damage response by modulating ATM signaling and homologous recombination pathways.
33. Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later Omicron subvariants.
34. Supplementary Figures S1-11 from CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy
35. Data from CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy
36. The investigation of selective sphingosine-1 phosphate receptor 1&4 modulator to treat alopecia areata mouse model
37. SARS-CoV-2 RBD-specific atypical memory B cells exhibit effector memory-like features in multi-dose mRNA vaccination
38. CEACAM marks intratumoral Tregs that exhibited highly suppressive and activated phenotypes
39. Supplementary Tables S1-7 from CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy
40. Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19
41. Supplementary Figure 6 from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
42. Supplementary Figure 2 from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
43. Supplementary Figure 3 from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
44. Data from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
45. Supplementary Figure 4 from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
46. Supplemental figure legends and table from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
47. Supplementary Figure 5 from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
48. Supplementary Figure 1 from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
49. Supplementary Table S2 from PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors
50. Supplementary Data from PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.